[News] Lenalidomide plus dexamethasone in multiple myeloma
In transplant-ineligible patients with newly diagnosed multiple myeloma, continuous treatment with lenalidomide plus dexamethasone improves survival outcomes, according to new research.
Source: The Lancet Oncology - Category: Cancer & Oncology Authors: Manjulika Das Tags: News Source Type: research